LONDON--(BUSINESS WIRE)--The report, global age-related macular degeneration (AMD) therapeutics market has been added to Technavios catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on type and geography for the forecast period 2019-2023.

To learn more about the global trends impacting the future of market research: Download Free Sample Report

This report on the age-related macular degeneration (AMD) therapeutics market includes:

Age-related macular degeneration (AMD) therapeutics market analysis and forecast 2019-2023: Features

Age-Related Macular Degeneration (AMD) Therapeutics Market 2019-2023: Competitive Landscape

Age-Related Macular Degeneration (AMD) Therapeutics Market 2019-2023: Geographic Landscape

Age-Related Macular Degeneration (AMD) Therapeutics Market 2019-2023: Type Landscape

Register for a free trial today and gain instant access to 10,000+ market research reports.Technavio's SUBSCRIPTION platform

High prevalence of AMD will drive the age-related macular degeneration (AMD) therapeutics market

The prevalence of AMD is increasing significantly, owing to the presence of high-risk factors such as aging, smoking, high cholesterol, and high blood pressure. Moreover, despite the high prevalence of AMD, no approved therapies are available in the market for the treatment of the condition. Thus, the high prevalence coupled with the huge unmet medical need of dry AMD are expected to drive market growth during the forecast period.

Development of gene therapy for AMD An emerging trend in the osteoporosis market

At present, only a few drugs are approved for the treatment of AMD. However, the side effects associated with them are very severe, and the majority of them act against VEGF only. Hence, there is a huge unmet need for safe and novel drugs to treat AMD. The currently available anti-VEGF therapies require repetitive and inconvenient intraocular injections. Hence, several companies are working on novel drugs to combat AMD, among which gene therapy is expected to cure the disease effectively. Hence, the development of gene therapy is expected to be a positive trend for the global AMD therapeutics market.

Other Key Topics Covered in the Report are:

MARKET LANDSCAPE

MARKET SIZING

Get Full Report: https://www.technavio.com/report/age-related-macular-degeneration-therapeutics-market-industry-analysis

CUSTOMER LANDSCAPE

DECISION FRAMEWORK

DRIVERS AND CHALLENGES

Market Trends

Technavio also offers Custom Research services providing focused, comprehensive, and tailored research.

For More Information Click Here

Browse Related Healthcare Reports:

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavios report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Original post:
Growth of Age-Related Macular Degeneration (AMD) Therapeutics Market to be Impacted by the Development of Gene Therapy for AMD | Technavio - Business...

Comments are closed.